CD8+ T cells were also more prevalent in the uninvolved colon of females (59.40% vs. 43.61%), and tumors in early-stage CRC (Stage I/II) had greater CD8+ infiltration compared to advanced-stage CRC (Stage III/IV) (37.01% vs. 23.91%). The gene discussed is CD8A; the disease is colorectal carcinoma.